congenital amegakaryocytic thrombocytopenia

Showing 1 - 6 of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +36 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 23, 2023

Bone Marrow Failure Syndrome, Congenital Amegakaryocytic Thrombocytopenia, Congenital Pure Red Cell Aplasia Trial in United

Recruiting
  • Bone Marrow Failure Syndrome
  • +6 more
  • Los Angeles, California
  • +23 more
Aug 15, 2022

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +77 more
  • fludarabine phosphate
  • +8 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Sep 16, 2019

Congenital Amegakaryocytic Thrombocytopenia, Diamond-blackfan Anemia, Leukemia Trial in San Francisco, Madison (biological,

Completed
  • Congenital Amegakaryocytic Thrombocytopenia
  • +4 more
  • alemtuzumab
  • +9 more
  • San Francisco, California
  • +1 more
Aug 30, 2017

Congenital Amegakaryocytic Thrombocytopenia, Leukemia, MDS Trial in San Francisco, Chapel Hill (biological, drug, procedure,

Completed
  • Congenital Amegakaryocytic Thrombocytopenia
  • +3 more
  • anti-thymocyte globulin
  • +7 more
  • San Francisco, California
  • +1 more
Nov 8, 2012

Congenital Amegakaryocytic Thrombocytopenia, Diamond-blackfan Anemia, Fanconi Anemia Trial in San Francisco (biological, drug,

Completed
  • Congenital Amegakaryocytic Thrombocytopenia
  • +5 more
  • anti-thymocyte globulin
  • +6 more
  • San Francisco, California
    UCSF Comprehensive Cancer Center
Nov 8, 2012